Does Increased Use of Antibiotics Result in Increased Antibiotic Resistance?

Davies, P. D. O.
July 2004
Clinical Infectious Diseases;7/1/2004, Vol. 39 Issue 1, p18
Academic Journal
Researchers have compared antibiotic consumption in British Columbia, Canada, with that in Denmark-regions with comparable population sizes but different geographic sizes in other European countries. They have also been able to show that with different antibiotic agents and classes come marked changes in use. For example, between 1996 and 2000, clarithromycin use increased by almost 50% in British Columbia, whereas erythromycin use decreased. In contrast, use of these antibiotics in Denmark showed little change. Antibiotic use according to age and sex was also examined. There is a presumption that increasing use of antibiotics must inevitably be associated with increasing resistance to antibiotics.


Related Articles

  • Various Novel Erythromycin Derivatives Obtained by Different Modifications: Recent Advance in Macrolide Antibiotics. Ma, C.; Ma, S. // Mini Reviews in Medicinal Chemistry;Apr2010, Vol. 10 Issue 4, p272 

    The rapid emergence of drug resistance intensified the search for new antimicrobial agents, leading to lots of novel derivatives obtained from 14- and 15-membered macrolides by chemical modifications. Many of them exhibited enhanced antibacterial activity and expanded antibacterial spectrum....

  • Lowering the rate of antibiotic resistance. Rohner, Clint D.; Force, Rex W. // Journal of Family Practice;Nov1997, Vol. 45 Issue 5, p374 

    The article presents a study which examined the impact of decreased macrolide use on the resistance rates of group A streptococci. Primary outcomes include the consumption of macrolide antibiotics and the resistance rate of group A streptococci to erythromycin. This study shows that the decrease...

  • Macrolide-Resistant Streptococcus pneumoniae and Use of Antimicrobial Agents. Pihlajamaki, Marja; Kotilainen, Pirkkp; Kaurila, Teemu; Klaukka, Timo; Palva, Erkki; Huovinen, Pentti // Clinical Infectious Diseases;8/15/2001, Vol. 33 Issue 4, p483 

    The prevalence of isolates of Streptococcus pneumoniae (pneumococcus) that are resistant to antimicrobial agents is increasing globally. We studied the connection between antimicrobial resistance of pneumococci and regional use of antimicrobial agents in Finland. In 1997, a total of 6106...

  • Mycoplasma pneumoniae Resistant to Macrolide Antibiotics.  // Clinical Infectious Diseases;4/15/2005, Vol. 40 Issue 8, preceding p1 

    The article presents information on mycoplasma pneumoniae resistant to macrolide antibiotics. Although no erythromycin-resistant M. pneumoniae isolates were detected in studies during 1983-1998, thirteen (17%) of 76 strains from 3 different regions of Japan isolated during 2000-2003 that were...

  • Macrolide Resistance in Bacteremic Pneumococcal Disease: Implications for Patient Management. Daneman, N.; McGeer, A.; Green, K.; Low, D. E. // Clinical Infectious Diseases;8/15/2006, Vol. 43 Issue 4, p432 

    Background. Despite pneumococcal antibiotic resistance rates in excess of 25%, macrolides remain first-line agents for the treatment of community-acquired pneumonia. Methods. Prospective, population-based surveillance was conducted to identify cases of pneumococcal bacteremia in Toronto and...

  • Topical Antibiotics Are Causing Increased Resistance.  // Review of Optometry;10/15/2011, Vol. 148 Issue 10, p10 

    The article offers information the study of Stephen Kim and colleagues concerning the use of topical antibiotics. According to Kim, the use of topical antibiotics promotes antimicrobial resistance. Moreover, the study reveals that repeated exposure to fluoroquinoline associated with...

  • The Importance of Resistance Rates When Selecting an Anti-Infective.  // Review of Ophthalmology;Aug2007 Part 1 of 2, Vol. 14 Issue 8, p38 

    The article presents an educational activity for ophthalmologists concerning the terms of resistance to anti-infectives including macrolides and fourth-generation fluoroquinolones. It provides information on the background of the study such as its learning objectives, accreditation statement and...

  • The Decline of Pneumococcal Resistance after Cessation of Mass Antibiotic Distributions for Trachoma. Haug, Sara; Lakew, Takele; Habtemariam, Gabremaskal; Alemayehu, Wondu; Cevallos, Vicky; Zhaoxia Zhou; House, Jenafir; Ray, Kathryn; Porco, Travis; Rutar, Tina; Keenan, Jeremy; Lietman, Thomas M.; Gaynor, Bruce D. // Clinical Infectious Diseases;9/1/2010, Vol. 51 Issue 5, p571 

    After 6 biannual mass distributions of oral azithromycin for trachoma in Ethiopian communities, 76.8% (95% confidence interval [CI], 66.3%-85.1%) of nasopharyngeal Streptococcus pneumoniae isolates from children aged 1-5 years were resistant to macrolides. Twelve and 24 months after the last...

  • Drug-resistant pneumococcal pneumonia: clinical relevance and approach to management. Fuller, J.; McGeer, A.; Low, D. // European Journal of Clinical Microbiology & Infectious Diseases;Dec2005, Vol. 24 Issue 12, p780 

    Community-acquired pneumonia is the most common infectious disease that causes death, with Streptococcus pneumoniae remaining the leading causative pathogen. The worldwide incidence of infections caused by pneumococci resistant to penicillin, macrolides, and other antimicrobial agents has...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics